how to wean off glp 1 Safely approaching Maintenance/Weaning GLP-1 treatments: A Comprehensive Guide Part 1 of a 3-Part

Conclusion Glucagon-like peptide-1 receptor agonists (GLP-1RAs) represent a promising therapeutic avenue for heart failure with preserved ejection fraction (HFpEF)

However, while the clinical results with semaglutide support indications for treatment of obesity per s (Wegovy R ) as well as T2D (Ozempic R ), weight reduction with these agents remains considerably less than the best surgical results, and is often only a fraction of what most patients require for correction of the co-morbidities of increased body weight

doi: 10.1046/j.1471-4159.2003.02073.x

Why GLP-1 Drugs May Have So Many Uses Although it isnt unusual for a drug to treat more than one disease, the wide range of illnesses under investigation with GLP-1 medications is notable

but on changing the course of disease itself

members might stop the drugs due to side effects, drug shortages, plan design or utilization management programs